Diabetic ketoacidosis.
In the past decade, considerable advances have occurred in our understanding of the pathophysiology of this disorder, its metabolic sequelae, and its management, particularly with respect to continuous low-dose insulin infusion and the potential benefits of phosphate. This article reviews these advances as they pertain to children.
D001639:Bicarbonates / Q000627:therapeutic use; D001929:Brain Edema / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D016883:Diabetic Ketoacidosis / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D004837:Epinephrine / Q000378:metabolism; D005440:Fluid Therapy; D005934:Glucagon / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D000078790:Insulin Secretion; D007657:Ketone Bodies / Q000378:metabolism; D010710:Phosphates / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D001639:Bicarbonates; D007328:Insulin; D007657:Ketone Bodies; D010710:Phosphates; D013006:Growth Hormone; D005934:Glucagon; D006854:Hydrocortisone; D004837:Epinephrine